Quadrant Capital Group’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Quadrant Capital Group's ASTH Position: Q2 2026 in Review
Quadrant Capital Group sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 186 shares — an estimated $4.56K sold.
Quadrant Capital Group first reported a position in ASTH in Q2 2021 and held it in 17 quarters. The position peaked at $105K in Q1 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Quadrant Capital Group reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 186 Astrana Health shares in Q2 2026, an estimated $4.56K.
- Quadrant Capital Group first reported a position in Astrana Health in Q2 2021 and held it in 17 quarters.
- Quadrant Capital Group's Astrana Health position peaked at $105K in Q1 2025.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.